Prior response to infliximab and early serum drug concentrations predict effects of adalimumab in ulcerative colitis
Author:
Affiliation:
1. Department of Gastroenterology; University Hospitals Leuven; Leuven Belgium
2. Department of Pharmaceutical and Pharmacological Sciences; Laboratory for Therapeutic and Diagnostic Antibodies; KU Leuven; Leuven Belgium
Publisher
Wiley
Subject
Pharmacology (medical),Gastroenterology,Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.12968/fullpdf
Reference26 articles.
1. Adalimumab in ulcerative colitis: ready for prime time;Danese;Dig Liver Dis,2013
2. Systematic review with network meta-analysis: the efficacy of anti-tumour necrosis factor-alpha agents for the treatment of ulcerative colitis;Stidham;Aliment Pharmacol Ther,2014
3. Review article: strategies for the management of chronic unremitting ulcerative colitis;Mehta;Aliment Pharmacol Ther,2013
4. Review article: the role of anti-TNF in the management of ulcerative colitis - past, present and future;Danese;Aliment Pharmacol Ther,2013
5. Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial;Reinisch;Gut,2011
Cited by 69 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Real-world effectiveness and safety of advanced therapies for the treatment of moderate-to-severe ulcerative colitis: Evidence from a systematic literature review;Journal of Managed Care & Specialty Pharmacy;2024-09
2. A prediction method for the individual serum concentration and therapeutic effect for optimizing adalimumab therapy in inflammatory bowel disease;Journal of Pharmacy and Pharmacology;2024-07-15
3. The Association between Genetics and Response to Treatment with Biologics in Patients with Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, and Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis;International Journal of Molecular Sciences;2024-05-26
4. Selection strategy of second-line biologic therapies in adult patients with ulcerative colitis following prior biologic treatment failure: Systematic review and meta-analysis;Pharmacological Research;2024-04
5. Tofacitinib uptake by patient-derived intestinal organoids predicts individual clinical responsiveness;2024-03-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3